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Abstract—Air pollution is a heterogeneous, complex mixture of gases, liquids, and particulate matter. Epidemiological
studies have demonstrated a consistent increased risk for cardiovascular events in relation to both short- and long-term
exposure to present-day concentrations of ambient particulate matter. Several plausible mechanistic pathways have been
described, including enhanced coagulation/thrombosis, a propensity for arrhythmias, acute arterial vasoconstriction,
systemic inflammatory responses, and the chronic promotion of atherosclerosis. The purpose of this statement is to
provide healthcare professionals and regulatory agencies with a comprehensive review of the literature on air pollution
and cardiovascular disease. In addition, the implications of these findings in relation to public health and regulatory
policies are addressed. Practical recommendations for healthcare providers and their patients are outlined. In the final
section, suggestions for future research are made to address a number of remaining scientific questions. (Circulation.
2004;109:2655-2671.)
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Recently, the American Heart Association (AHA) pub-lished “Guidelines for Primary Prevention of Cardiovas-
cular Disease and Stroke” as an aid to healthcare profession-
als and their patients without established coronary artery
disease or other atherosclerotic diseases.1 The statement was
intended to complement the AHA/American College of
Cardiology (ACC) “Guidelines for Preventing Heart Attack
and Death in Patients with Atherosclerotic Cardiovascular
Disease.”2 Both sets of recommendations emphasized multi-
factorial interventions, especially more intensive measures/
goals to modify individual cardiovascular risk factors with
diet, drugs, exercise, weight management, complete smoking
cessation, and avoidance of secondhand smoke (SHS), or
combinations thereof.
Over the last decade, however, a growing body of epide-
miological and clinical evidence has led to a heightened
concern about the potential deleterious effects of ambient air
pollution on health and its relation to heart disease and stroke.
Of special interest are several environmental air pollutants
that include carbon monoxide, oxides of nitrogen, sulfur
dioxide, ozone, lead, and particulate matter (“thoracic parti-
cles” [PM10] 10 m in aerodynamic diameter, “fine parti-
cles” [PM2.5] 2.5 m, and “coarse particles” [PM10 to 2.5]).
These pollutants are associated with increased hospitaliza-
tion3 and mortality due to cardiovascular disease,4–6 espe-
cially in persons with congestive heart failure, frequent
arrhythmias, or both.7 The well-established causal associa-
tions between active and passive smoking with heart disease
and stroke support the plausibility of an adverse effect of PM
on the cardiovascular system.
The most recent analysis of the National Mortality and
Morbidity Air Pollution Study (NMMAPS), based on data
from 90 of the largest cities in the United States, estimated
that daily total and cardiopulmonary mortality increased in
the short term by 0.21% (0.06 standard error [SE]) and
0.31% (0.09 SE), respectively, for each 10-g/m3 increase
in PM10 (measured over a 24-hour period).8 To give some
context to a 24-hour PM10 increment of 10 g/m3, the US
Environmental Protection Agency (EPA) reported a range of
maximum city-specific 24-hour PM10 concentrations from 26
to 534 g/m3.9 Data from the American Cancer Society
(ACS) cohort5 estimated that for each 10-g/m3 increase in
annual average exposure to PM2.5, long-term all-cause, car-
diopulmonary, and lung cancer mortality were increased by
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approximately 4%, 6%, and 8%, respectively. On the basis of
a job exposure matrix, Gustavsson et al10 reported increasing
risks of myocardial infarction among 3000 Swedish work-
ers with increasing cumulative exposure to products from
nonvehicular combustion processes.
To evaluate whether high concentrations of ambient parti-
cles can trigger the onset of acute myocardial infarction
(AMI), Peters and associates,11 using a case-crossover ap-
proach, interviewed 772 patients with AMI as part of the
Determinants of Myocardial Infarction Onset Study. Elevated
concentrations of PM2.5 were associated with a transient risk
of AMI onset during 2 separate time periods (within 2 hours
and 1 day after exposure). On the other hand, investigators in
Seattle, Wash, did not find an association between high levels
of PM10 and the occurrence of primary cardiac arrest that
occurred outside of the hospital in presumably healthy
adults12 or in subjects with known underlying heart disease.13
A recent report by Suwa et al14 provides experimental
evidence to support the hypothesis that these epidemiological
data truly reflect the deleterious effects of particulate pollu-
tion on the cardiovascular system. Compared with their
control counterparts, hyperlipidemic rabbits exposed to PM10
showed more advanced coronary lesions, increased plaque
size, more extensive atherosclerosis in the aorta, and an
increase in the volume fraction of lesions composed of lipids
(ie, plaques more likely to rupture).15 Other contemporary
studies suggest that possible links between acute and/or
chronic exposure to PM and cardiovascular events may be
related to increases in heart rate and blood pressure, fibrino-
gen, and blood coagulation factors; arterial vasoconstriction;
inflammatory mediators (eg, C-reactive protein [CRP]); en-
dothelial injury/dysfunction; and decreases in heart rate
variability (HRV).16 Consequences of these effects may
include myocardial ischemia (manifested as significant ST-
segment depression during exercise testing,17 angina pectoris,
or both), malignant ventricular arrhythmias,18 increased
plaque vulnerability, and enhanced potential for acute throm-
bosis triggering acute coronary syndromes. Further support
that these changes can be attributed to air pollution comes
from studies of the effects of SHS, which is the single largest
contributor to indoor PM19 when a smoker is present. Expo-
sure to SHS increases platelet activation,20 causes rapid
deterioration in endothelial function,21,22 promotes athero-
sclerotic plaque development,23 and abets infarct expansion in
experimental animals.24 Because exposure to the SHS of just
1 cigarette per day accelerates the progression of atheroscle-
rosis,25 it is plausible that even low doses of air pollution
could have negative effects on coronary morphology and
circulation.
Collectively, these and other studies (described herein)
suggest that air pollution may accelerate the development of
coronary atherosclerosis and worsen its sequelae. Some of
these effects may occur over time, as with acceleration of the
progression of atherosclerosis, or rather abruptly, as with the
triggering of an arrhythmia or myocardial infarction by acute
inflammatory responses, altered platelet adhesiveness, or
perhaps vascular endothelial dysfunction. This AHA scien-
tific statement provides healthcare professionals and regula-
tory agencies with a comprehensive review of the relationship
between air pollution and cardiovascular disease. A brief
description of the different types of air pollutants is provided
first for background. In the remaining sections, the focus of
this statement is on PM, with occasional references to the
health effects of other pollutants, alone or in combination.
The link between SHS and heart disease is outlined next,
which provides a relevant model for the cardiovascular
effects of air pollution. In the following sections, many of the
pertinent epidemiological studies and the potential patho-
physiological mechanisms underlying the increased risk of
cardiovascular events due to PM are discussed. In the
summary and conclusion sections, the implications of these
data regarding public health policy and unanswered (future)
research questions are addressed.
Ambient Air Pollutants
A brief description of several individual air pollutants is
provided first for background. A complete discussion is
beyond the scope of this statement, and interested readers
may find a more comprehensive review on this subject
elsewhere.26
Particulate Matter
Airborne PM consists of a heterogeneous mixture of solid and
liquid particles suspended in air, continually varying in size
and chemical composition in space and time (Figure 1).
Primary particles are emitted directly into the atmosphere,
such as diesel soot, whereas secondary particles are created
through physicochemical transformation of gases, such as
nitrate and sulfate formation from gaseous nitric acid and
sulfur dioxide (SO2), respectively. The numerous natural and
anthropogenic sources of PM include motor vehicle emis-
sions, tire fragmentation and resuspension of road dust,
power generation and other industrial combustion, smelting
and other metal processing, agriculture, construction and
demolition activities, residential wood burning, windblown
soil, pollens and molds, forest fires and combustion of
agricultural debris, volcanic emissions, and sea spray. Al-
though there are thousands of chemicals that have been
detected in PM in different locations, some of the more
common constituents include nitrates, sulfates, elemental and
organic carbon, organic compounds (eg, polycyclic aromatic
hydrocarbons), biological compounds (eg, endotoxin, cell
fragments), and a variety of metals (eg, iron, copper, nickel,
zinc, and vanadium).
Largely because of the complex nature of PM, it has been
measured and regulated based primarily on mass within
defined size ranges. In 1987, the regulatory focus shifted
from total suspended particles to particles that could readily
penetrate and deposit in the tracheobronchial tree, or PM10
(PM with a median aerodynamic diameter of 10 m). In
1997, the US EPA promulgated 24-hour and annual average
standards for PM2.5 (PM with median aerodynamic diameter
2.5 m), comprising the size fraction that can reach the
small airways and alveoli. The existing federal PM10 stan-
dards were retained, however, to address health effects that
could be related to the “coarse fraction” (PM10 to 2.5). Cur-
rently, a separate PM10 to 2.5 standard is under consideration. In
general, PM2.5 originates mostly from combustion sources and
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includes primary and secondary particles, whereas the coarse
fraction derives predominantly from natural sources, espe-
cially crustal material (including windblown soil) and grind-
ing processes. Important bioaerosols (eg, endotoxin, pollen
grains, and fungal spores) are found mostly in the coarse
fraction (and larger particles), although both endotoxin (an
essential component of the cell wall of Gram-negative bac-
teria) and the antigenic protein content of pollen grains can
also adsorb onto the surface of fine PM. Generally, larger
particles demonstrate a greater fractional deposition in the
extrathoracic and upper tracheobronchial regions, whereas
smaller particles (eg, PM2.5) show greater deposition in the
deep lung. Although PM2.5 generally behaves as a regional
pollutant, there can be considerable small-scale spatial vari-
ability due to point source emissions (eg, a smelter) or
features such as street canyons in large cities. In addition,
prevailing wind patterns can affect human exposures.
More recently, considerable research attention has been
devoted to ultrafine particles (UFPs) 100 nm (0.1 m) in
diameter, which result from combustion processes. UFPs tend
to be short-lived, because they agglomerate and coalesce into
larger particles. However, they demonstrate very high depo-
sition in human alveoli,27 account for a major portion of the
actual numbers of particles within PM, and have a high
surface area-to-mass ratio, potentially leading to enhanced
biological toxicity. UFPs may even be able to pass directly
into the circulatory system, which could allow them to be
disseminated systemically.28–30
Nitrogen Oxides
Nitrogen oxides are reactive substances commonly under-
stood to encompass nitric oxide (NO), nitrogen dioxide
(NO2), nitrogen trioxide, nitrogen tetroxide (N2O4), and di-
nitrogen pentoxide (N2O5). These compounds are referred to
collectively as “NOX.” Gaseous nitric acid (HNO3), a major
source of particulate nitrate, is formed when NO2 reacts with
hydroxyl radicals during the day and when N2O5 reacts with
water vapor at night.31 Other members of the larger family of
nitrogen oxides include nitrous acid, nitrous oxide, peroxy-
acetyl nitrate (responsible for some of the irritant effects of
photochemical smog), nitrites, nitroso compounds, and other
nitrogen-containing acids. Most toxicological and epidemio-
logical research has focused on NO2, because of the fact that
(1) NO2 is one of the regulated air pollutants for which
standards are available worldwide; (2) NO from vehicular
exhaust and power plants is largely converted to NO2; and (3)
NO2 plays a primary role in the formation of tropospheric
ozone (O3).
The main anthropogenic source of NOX in ambient air is
fossil fuel combustion in motor vehicles and industrial
processes, particularly in power generation. High-
temperature combustion results in the oxidation of atmo-
spheric N2, first to NO and then to NO2. Motor vehicle
emissions near busy streets can result in high local NOX
concentrations. The typical diurnal NOX pattern consists of a
low background concentration, with morning and late after-
noon peaks resulting from rush-hour traffic. Nitrogen in fossil
fuels such as coal can be oxidized to NO2 under oxygen-rich
combustion conditions. NO2 and NO are both formed natu-
rally as a result of bacterial metabolism of nitrogenous
compounds and, to a lesser extent, from fires, volcanoes, and
fixation by lightning. The generation of tropospheric ozone
and other photochemical oxidants is initiated with photolysis
of NO2, whereas NO acts as an ozone scavenger.32
Significant human exposure can occur in nonoccupational
indoor settings.33,34 Gas-burning appliances, such as unvented
furnaces and stoves, are the principal sources of indoor NOX,
although kerosene space heaters and tobacco smoke may also
play a role.35,36 In urban areas, infiltration of ambient NO2
from vehicular emissions may also influence indoor expo-
sures.33 Several reports have also documented toxic concen-
trations of NO2 in ice-skating rinks.37,38
Carbon Monoxide
Carbon monoxide (CO) is a nearly ubiquitous product of
incomplete combustion of carbon-containing fuels. Outdoor
Figure 1. Particulate matter air pollution
size distribution.
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sources include motor vehicles; engines on motorboats,
lawnmowers, chain saws, and other devices that require fossil
fuel combustion; residential wood burning; improperly ad-
justed gas-burning and oil appliances; coal combustion; and
tobacco smoking.39,40 In urban areas, the contributions of
diesel and stationary source combustion are relatively small
in relation to gasoline-powered engines.41
CO is an odorless, colorless, and tasteless gas that binds to
hemoglobin with an affinity 250 times that of oxygen, thereby
interfering with the systemic delivery of oxygen to tissues. In
addition, binding of CO to hemoglobin causes an allosteric
change in the conformation of the oxyhemoglobin complex
that increases the oxygen affinity of the remaining binding
sites and interferes with the release of O2 at the tissue level.
In addition, CO binds to cytochrome oxidase, exacerbates
cellular hypoxia, and binds to other extravascular proteins
that include myoglobin, cytochrome P-450, catalase, and
peroxidases.42 Given current ambient CO concentrations in
the United States, it is likely that in most circumstances, this
pollutant serves more as an indicator of combustion-related
pollution than as a direct toxicant. However, in some situa-
tions (eg, insufficiently ventilated parking structures), CO
could attain concentrations sufficient to lead to physiologi-
cally meaningful increases in carboxyhemoglobin in persons
with significant atherosclerotic disease or other cardiac
conditions.
Sulfur Dioxide
Sulfur dioxide (SO2) is a highly irritating, colorless, soluble
gas with a pungent odor and taste. In contact with water, it
forms sulfurous acid, which accounts for its strong irritant
effects on eyes, mucous membranes, and skin.43 SO2 is
efficiently scrubbed from inhaled air in the upper airway.
In the absence of human activities, background concentra-
tions of ambient SO2 are very low, in the range of 1 ppb. In
ambient air, the principal sources of SO2 include combustion
of sulfur-containing fuels, especially in power plants and
diesel engines (prior to the reformulation of diesel fuels), and
roasting of metal sulfide ores. Sulfur dioxide is oxidized to
sulfur trioxide, which, because of its strong affinity for water,
can be rapidly hydrated to form sulfuric acid.44 Elevated
levels of SO2 have been associated with widespread illness in
several 20th century air pollution catastrophes; however,
much of the morbidity and mortality in these episodes may
have been due to its role in the formation of particulate
sulfates. In nonoccupational settings, SO2 is generally found
at substantially lower concentrations indoors than outside;
however, the use of kerosene space heaters can generate
significant indoor concentrations.35
Ozone
Ozone (O3) is a highly reactive, colorless-to-bluish gas with a
characteristic odor associated with electrical discharges.43
Low-level exposure is ubiquitous, because O3 is formed by
natural processes and by human activities. Ozone is formed in
the stratosphere by the action of solar radiation on molecular
oxygen (O2). Because stratospheric O3 prevents high-energy
UV radiation from penetrating the atmosphere, many terres-
trial life forms would be unable to survive without this O3
“shield.”
O3 has been recognized since the 1950s as the principal
component of photochemical smog. In the troposphere, it is
formed by the action of solar UV radiation on nitrogen oxides
and reactive hydrocarbons, both of which are emitted by
motor vehicles and many industrial sources. The reaction
sequence involves photolysis of NO2 into NO and oxygen
atoms. The latter react with molecular oxygen to form O3.
NO, however, rapidly scavenges O3, regenerating NO2 and




where M represents any nearby molecule that can absorb the
energy of the reaction. Under steady-state conditions, there is
little accumulation of O3. However, many reactive organic
compounds can facilitate the oxidation of NO to NO2 by
alternative mechanisms. These reactions reduce NO scaveng-
ing, which allows O3 concentrations to increase.45
Photochemical O3 formation tends to be greatest on warm,
sunny days. The typical profile of tropospheric O3 formation
in populated areas is characterized by a broad peak that lasts
from the late morning until the late afternoon or early
evening. However, large-scale transport may result in ele-
vated O3 concentrations that extend over thousands of square
miles to include rural areas far removed from the precursor
sources. Thermal inversion height, wind speed and direction,
addition of other O3 precursors along an air mass trajectory,
and other factors affect the temporal O3 patterns downwind,
so that peak concentrations may occur anytime from noon
until late in the evening.46 Human activities are major sources
of O3 precursors, although the latter are also generated by
nonanthropogenic processes that include the intrusion of
stratospheric O3, the action of lightning on molecular oxygen,
and chemical reactions involving naturally occurring nitrogen
oxides and organic compounds, such as biogenic methane and
other volatile organic compounds.45
Secondhand Smoke
The national awareness of SHS as a major risk factor for
chronic disease was substantially heightened with the 1986
Report of the Surgeon General, “The Health Consequences of
Involuntary Smoking,”47 and the 1992 EPA report on the
respiratory health effects of SHS.48 The primary focus of the
Surgeon General’s report was on lung cancer and other
respiratory diseases,47 although evidence linking passive
smoking to heart disease was just beginning to emerge.49
Similarly, the EPA report focused primarily on the impact of
SHS on lung cancer and asthma50 by reporting that an
estimated annual 3000 lung cancer deaths could be attributed
to SHS.48
There is also clear evidence of an association of SHS and
cardiovascular diseases. Several reports, including 2 recent
separate meta-analyses of 17 and 18 individual studies,
assessed the association of SHS with heart disease.20,51–53
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Both estimated that nonsmoking spouses of smoking partners
experience an approximately 25% (95% confidence interval
[CI] 17% to 32%) increased risk of heart disease.52,53 A
review of 6 studies examining the association between SHS
in the workplace and cardiovascular disease noted that
although none of the studies individually reached the level of
a significant association (P0.05), there was a positive
association in 5 of the 6 studies and a significant exposure-
response relation between the intensity of SHS (measured by
the number of cigarettes smoked by coworkers) and coronary
risk in 2 of 3 studies that examined the trend.54
It is likely that SHS acts to increase cardiac risk through
both chronic (atherogenic) and acute pathways. A review of
the association of SHS and subclinical measures of athero-
sclerosis reported a consistent association of significantly
increased intima-medial thickness of the carotid artery in 8
reports.55 In addition, exposure to SHS has been shown
experimentally to have effects on endothelium-dependent
arterial dilatation21,22 and coronary flow reserve in humans.56
Initial reports on an association between SHS and stroke
support the observed association with heart disease. Two
case-control studies have shown significantly increased odds
ratios of clinical stroke with exposure to SHS: 1.72 (95% CI
1.07 to 2.77) and 2.59 (95% CI 1.51 to 4.47) for exposure to
a spouse smoking 1 to 20 cigarettes a day and 21 cigarettes
per day,57 respectively, and 1.82 (95% CI 1.34 to 2.49) for
SHS exposure at home or work for at least 1 year during the
decade preceding the event.58 There was a 6% (95% CI 0.64
to 1.75) increased odds of silent cerebral infarction in a
population-based cohort study of nonsmokers exposed to
SHS in relation to those not exposed; however, this difference
did not reach statistical significance.59
The impact of SHS on heart disease and stroke is also
supported by the remarkable “natural experiment” observed
when Helena, Mont, banned public smoking beginning June
5, 2002. During the 6-month period of the ban, admissions to
the local hospital for acute myocardial infarction dropped by
40%, a decline that was not observed in any of the other
hospitals from surrounding communities.60 The study inves-
tigators hypothesized that the reduction in hospital admis-
sions was due to acute coagulation changes associated with
reduced SHS exposure.
A recent review of the studies concluded that it is unlikely
that experimental biases can invalidate the general conclu-
sions of the epidemiological studies.61 Moreover, the review
cites the strong experimental evidence that provides a bio-
logical basis for the observed associations between SHS
exposure and increased risk of cardiovascular disease.61
The importance of SHS as a public health issue comes
from the high prevalence of SHS exposure in the general
population. On the basis of the most recent data from the
National Health Interview Survey, the prevalence of active
cigarette smoking was 21.4% (95% CI 20.2% to 22.5%) in
2003.62 NHANES III (1988–1991) found that 90% of
tobacco nonusers have detectable levels of serum cotinine,63
which suggests that as much as 65% of the entire population
are nonsmokers exposed to SHS. This arises primarily from
exposures at home or at the workplace. Between 1988 and
1991, among adult nonsmokers, 37% reported living in a
home with at least 1 smoker or being exposed to SHS at
work.63 Forty-three percent of children lived in a home with
at least 1 smoker, higher than the percentage observed among
adults, which is due in part to children’s opportunity to be
exposed to SHS by either a smoking mother or father.63 More
recent reports available at the CDC website suggest that there
may be substantial decreased exposure to SHS over the
interval from 1991–1994 to 1999–2000, with decreased
levels of cotinine in children (58%), adolescents (55%),
and adults (75%).63a
Exposure to SHS in workplace settings is also surprisingly
high. Nineteen states participating in the Centers for Disease
Control and Prevention’s Behavioral Risk Factor Surveil-
lance System included questions related to working in a
smoke-free workplace during 1999. The survey reports a
prevalence range of exposure to cigarette smoke at work from
18% (District of Columbia) to 38% (Mississippi).64 Some
other studies reported even higher rates.65,66
SHS exposure is associated with well-established increases
in relative risks for circulatory diseases. It directly affects, at
some level, perhaps as much as two thirds of the population,
with some suggestion that the proportion exposed may be
decreasing. Although the increased risk for cardiovascular
diseases associated with SHS exposure (relative risk [RR]
1.25) has not drawn attention to it as a “major” cardiovascular
risk factor, the high prevalence of exposure does make it a
major public health issue. Given past patterns of exposure, it
has been estimated that between 35 000 and 65 000 ischemic
heart disease deaths result from SHS annually.67,68 This is an
order of magnitude greater than the estimated 3000 annual
deaths from lung cancer. As such, SHS “pollution” represents
a substantial public health burden, ranking it as one of the
most important preventable causes of cardiovascular death.
Epidemiology of Ambient Air Pollution and
Cardiovascular Disease
An association between high levels of anthropogenic air
pollutants and human illnesses has been known for more than
half a century. A few episodes of markedly increased mor-
tality rates during extreme elevations in urban pollution, such
as in the Meuse Valley, Belgium, in December 193069 and
during the London fog incident of 1952,70 sparked the initial
epidemiological research. As a result, a several-decades-long
effort to reduce air pollution ensued and culminated in the
Clean Air Act legislation of 1970. Despite improvements in
air quality over the past few decades, associations between
current ambient pollution levels and excess morbidity and
mortality have been consistently detected.71–76
There are several hundred published epidemiological stud-
ies linking air pollution with human illnesses. A number of
extensive reviews on this topic are available.77–79 Although
many pollutants may cause disease individually or in combi-
nation (eg, O3, SO2, and NO2),80 over the past decade, PM has
become a major focus of research. During the past 15 years,
the magnitude of evidence and number of studies linking air
pollution to cardiovascular diseases has grown
substantially.77,78
In broad terms, studies can be separated into those that
have investigated the health effects of acute or chronic air
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pollution exposure. Observations related to the adverse health
effects of short-term exposure are more numerous. In these
studies, population-wide changes in acute outcomes (mortal-
ity, symptomatology, hospitalizations, and healthcare visits)
are linked to short-term variations in ambient pollutant
concentrations, most frequently through the use of
population-based time-series analysis. More recently, case-
crossover designs have been added to the analytical reper-
toire. Publications on the health effects of long-term exposure
are few. These studies have involved analysis of data (eg,
total mortality and in some circumstances cardiovascular
events) from a few large cohorts from multiple geographic
locations that differ in the average chronic ambient concen-
trations and mixtures of air pollutants.
Long-Term Health Effects Studies
The first large, prospective cohort study that demonstrated an
adverse health impact of long-term air pollution exposure was
the Harvard Six Cities study by Dockery et al.81 This study
demonstrated that chronic exposure to air pollutants is inde-
pendently related to cardiovascular mortality. In a cohort of
8111 adults with 14 to 16 years of follow-up, the adjusted
overall mortality rate ratio for the most-polluted city versus
the least-polluted city was 1.26 (95% CI 1.08 to 1.47).
Further adjustment for a variety of individual-level risk
factors that included tobacco smoking, gender, body mass
index, educational attainment, occupational exposures, hyper-
tension, and diabetes did not significantly alter the relation-
ship. Cardiovascular deaths accounted for the largest single
category of the increased mortality. Of the 1401 validated
deaths, 646 were due to cardiovascular causes (International
Classification of Diseases, 9th Revision [ICD-9] codes 400 to
440). The risk ratios for lung cancer and overall cardiopul-
monary mortality were increased by similar magnitudes.
Among air pollutants, elevations of PM2.5 and sulfates showed
the strongest associations with disease.
These findings were complemented by similar observa-
tions from the first analysis of air pollution in relation to
mortality in the ACS Cancer Prevention II study population.82
Recently, a follow-up of the original ACS cohort by Pope et
al,5 based on additional subject mortality and ambient pollut-
ant data, has provided the largest study of the long-term
health effects of air pollution. In approximately 500 000
adults who resided in all 50 states, chronic exposure to
multiple air pollutants was linked to mortality statistics for a
16-year period. The ACS follow-up study increased the
degree of control for confounding variables, such as diet and
gaseous copollutants. The primary results showed that each
10-g/m3 increase in annual PM2.5 mean concentration, based
on a number of different averaging periods, was associated
with increases in all-cause, cardiopulmonary, and lung cancer
mortality of 4%, 6%, and 8%, respectively. The relationship
between PM2.5 and adverse health effects was linear and
without a discernible lower “safe” threshold. Mortality was
most strongly associated with PM2.5, sulfate particles, and
SO2. There also appeared to be an association between
cardiopulmonary mortality and summertime O3, when based
on mean summer O3 levels from 1982 to 1998. Educational
level was a modifier of the risks estimated for PM-associated
mortality. The increased risks were limited to those with no
more than a high school education. This suggests that 1 or
more unaccounted-for factors, such as intraurban geographic
location or socioeconomic status, may be important determi-
nants of health risk.
Hoek et al83 confirmed the importance of within-city
residential variations as a risk factor for mortality due to air
pollution. In a cohort of 5000 adults followed up for 8 years,
exposure to traffic-related air pollutants was more highly
related to mortality than were citywide background levels. Of
the various pollutant metrics, an indicator variable for living
near a major road was most strongly associated with cardio-
pulmonary mortality in this cohort (RR 1.95, 95% CI 1.09 to
3.52). This study suggests that an individual’s exposure to the
“toxic” components of air pollution may vary as much within
a single city as across different cities. Furthermore, it dem-
onstrates that emissions from motor vehicles, a common
source of urban air pollution, may be associated with an
increased risk of mortality.
Until recently, the specific causes of the increased cardio-
vascular mortality due to long-term air pollution exposure
have remained unclear. In an analysis of the ACS study
published this year, the investigators reported PM-mortality
associations with the specific cause of death.4 A statistically
robust association between PM2.5 and overall cardiovascular
mortality was confirmed for a 10-g/m3 increase in long-term
exposure (RR 1.12, 95% CI 1.08 to 1.15). The single largest
increase in risk was for ischemic heart disease (RR 1.18, 95%
CI 1.14 to 1.23), which also accounted for the largest
proportion of deaths. In addition, the risk for arrhythmia,
heart failure, or cardiac arrest mortality was also increased
(RR 1.13, 95% CI 1.05 to 1.21). There was no evidence for
excess mortality in the entire cohort due to other reasons (eg,
aortic aneurysms, stroke, diabetes, hypertensive disease, or
any respiratory illness). These findings suggest that air
pollution promotes both ischemic and nonischemic cardio-
vascular events.
Short-Term Health Effects Studies
The Six Cities81 and ACS4,5,82 studies provide strong evi-
dence for the occurrence of adverse cardiovascular effects
due to long-term air pollution exposure. However, many
more studies have focused on short-term relationships be-
tween pollution exposure and adverse outcomes. The acute
effects of air pollution are generally investigated by time-
series analyses of changes in health outcomes (eg, mortality)
in relation to day-to-day variations in ambient air pollution
concentrations. The 2 largest studies to date are the
NMMAPS in the United States6,8 and the Air Pollution and
Health: a European Approach (APHEA-2) project.84 These
studies produced remarkably consistent results.
The NMMAPS observed outcomes in 50 million people in
the 20 largest cities in the United States. Average mortality
rates were independently associated with particle concentra-
tions the day before death. Each 10-g/m3 elevation in PM10
was associated with an increase of 0.21% (0.06 SE) and
0.31% (0.09 SE) for daily all-cause and cardiopulmonary
mortality, respectively.8
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The APHEA-2 study demonstrated slightly more robust
associations between adverse health outcomes and air pollu-
tion.84 For 43 million people in 29 European cities, the
estimated increase in daily mortality was 0.6% (95% CI 0.4%
to 0.8%) for each 10-g/m3 increase in PM10. Cardiovascular
deaths were increased by 0.69% (95% CI 0.31% to 1.08%).85
APHEA-2 based calculations on average particle concentra-
tions the day of and 1 day before observed health outcomes (a
2-day exposure time window). The NMMAPS investigators
reported no differences among various lag time periods from
0 to 2 days and therefore based their estimates solely on the
prior 24-hour period (1-day lag). The size of the observed
health effect in a study is known to vary slightly depending on
exposure metric and lag periods used in analyses. This may
have contributed to the stronger associations found in the
European study. Additional analyses of the APHEA-2 mor-
tality data, based on lag periods up to 40 days, found that the
risk of adverse health effects associated with air pollution
more than doubled (eg, 1.97% increase in cardiovascular
mortality [95% CI 1.38% to 2.55%] per 10-g/m3 elevation
in PM10).85 This finding indicated that the increase in cardio-
pulmonary mortality was not simply the result of “harvest-
ing” (also called mortality displacement, which refers to the
advancement of death by no more than a few days for
severely ill individuals). Analyses of data from other loca-
tions also have indicated that the increased risks cannot be
explained solely by harvesting and that longer lags are
associated with higher relative risks of cardiopulmonary
mortality.86–88 The higher relative risks demonstrated by
using this statistical modeling may reflect the accumulation
of both acute and subacute health effects over the longer lag
periods.
APHEA-2 found that cities with higher levels of the
copollutant NO2 exhibited larger associations between
changes in PM concentrations and mortality. In the United
States, this modifying effect of NO2 was not demonstrated.
The APHEA-2 investigators speculated that this might reflect
a higher proportion of NO2 that is derived from diesel exhaust
in Europe. Outcome differences by geographical region were
also noted in both studies. In Europe, cities with warmer
climates demonstrated stronger mortality associations with
air pollutants. The NMMAPS study in the United States
reported stronger relationships in the Northeast than the
Southeast. It is plausible that differences in the underlying
susceptibility of the populations, time spent outdoors, com-
mute times, and ambient meteorology, as well as differences
in the overall ambient pollutant mixtures, underlie the ob-
served regional variability in risk estimates for both studies.
Hundreds of smaller, short-term studies have been pub-
lished over the last few decades on the effects of acute air
pollution exposure, as reviewed by Brunekreef and Holgate77
and Pope.78 Typically, short-term mortality rates73,88 hospital
admissions,89–91 emergency room visits,92,93 and symptom
exacerbations94,95 have been shown to increase in relation to
variations in air pollution levels (time-series studies). Obser-
vations from across North America96,97 and Europe3,98 have
demonstrated higher rates of hospitalizations for all cardio-
vascular causes. Direct associations have also been identified
with respect to incidence of ischemic heart disease, arrhyth-
mias, and heart failure.98 A pooled analysis of hospital
admissions studies showed significant increases in admission
rates of 0.8% and 0.7% for heart failure and ischemic heart
disease, respectively, for each 10-g/m3 elevation in PM10.99
More focused investigations have demonstrated elevated
risks for AMI,11 implantable cardioverter defibrillator dis-
charges,18 and myocardial ischemia during stress testing.17
Extreme elevations in air pollution have also been associated
with increased blood pressure during a prolonged air stagna-
tion episode in Europe.100 Finally, recent studies from Seoul,
South Korea101 and Taiwan102 have reported higher inci-
dences of ischemic strokes in direct relation to changes in
ambient particle concentrations. In summary, these findings
imply that short-term elevations in ambient particle levels are
capable of evoking cardiac arrhythmias, worsening heart
failure, and triggering acute atherosclerotic/ischemic cardio-
vascular complications.
Populations at Elevated Risk
It is now reasonably well established that both short-term and
chronic air pollution exposures are related to cardiovascular
diseases. Whether there are specific individuals or subsets of
patients at increased relative risk is less well documented. A
few observations have suggested that the elderly5,81,84,103 and
those with less than a high school education (low socioeco-
nomic status) may be particularly susceptible populations.5
Whether increased age per se or the high prevalence of
underlying cardiovascular disease and other risk factors
explains the enhanced risk observed in elderly populations is
unclear. The presence of preexisting chronic lung disease,
coronary heart disease, and heart failure may also elevate
short-term cardiovascular mortality risk.103 Most recently,
publications from 2 separate groups provide evidence that the
acute risk for cardiovascular events in patients with diabetes
mellitus may be 2-fold higher than for nondiabetics.104,105 It is
plausible that both diabetes itself and the high incidence of
concomitant cardiovascular disease may explain this relation-
ship. There is no convincing evidence that gender, race, and
other preexisting coronary risk factors (eg, obesity, dyslipid-
emia, and hypertension) increase the risk of cardiovascular
events due to air pollution.
The effect of tobacco smoking on the cardiovascular risk
due to long-term air pollution exposure was recently investi-
gated in the large ACS study.4 The risks for specific cardio-
vascular causes of death for each 10-g/m3 increase in the
long-term exposure to PM2.5 were stratified by smoking
status. Ischemic heart disease mortality was consistently
elevated, with RRs of 1.22 (95% CI 1.14 to 1.29), 1.15 (95%
CI 1.07 to 1.23), and 1.16 (95% CI 1.07 to 1.27) for
never-smokers, former smokers, and current smokers, respec-
tively. Interestingly, smoking status clearly affected the risk
associated with several other causes of death. The risk due to
arrhythmias, heart failure, and cardiac arrest was not signif-
icantly elevated for those who never smoked (RR 1.04 [95%
CI 0.95 to 1.15]). However, among former and current
smokers, the risk increased substantially, with RRs of 1.14
(95% CI 1.00 to 1.29) and 1.31 (95% CI 1.12 to 2.19),
respectively. Mortality risk due to hypertensive disease was
also only increased in patients who actively smoked (RR
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1.57, 95% CI 1.12 to 2.19). These findings show that
smoking, while not affecting the PM-associated risk from
ischemic heart disease, appeared to interact with air pollution
to increase the risk of death from other circulatory diseases.
Environmental Pollution and Congenital
Heart Disease
Malformations of the cardiovascular system are among the
more frequently occurring congenital defects. The incidence
of congenital heart disease is estimated at 8.1 per 1000
births.106 The actual rate may be underestimated, because
some cases may be lethal in utero and result in spontaneous
abortion and stillbirths. Congenital heart disease is associated
with genetic defects, infections (eg, rubella), radiation, med-
ications, and environmental exposures.106–111 Recent data
from Eastern Europe in areas with high levels of industrial
pollution suggest the possibility of increased heart defects.112–
114 More recently, a study of birth records in Los Angeles,
Calif, found that odds ratios (ORs) for cardiac ventricular
septal defects increased in a dose-response fashion with
increasing carbon monoxide exposure (OR for second quar-
tile 1.62 [95% CI 1.05 to 2.48], OR for third quartile 2.09
[95% CI 1.19 to 3.67], and OR for fourth quartile 2.95 [95%
CI 1.44 to 6.05]).115 Also observed were valvular, aortic, and
truncal defects associated with O3 levels. PM and other
measured air pollutants showed no association. Although
some animal data also suggest a relationship between air
pollutants and congenital cardiac defects, these epidemiolog-
ical data can only be considered suggestive at this time.
Significance of Epidemiological Findings
Epidemiological research has served to drive major govern-
mental regulations and thus has been the subject of intense
scrutiny. Two of the largest studies of the health effects of
long-term air pollution exposure81,82 that have served as the
basis for the setting of annual average PM2.5 standards have
undergone complete reanalyses by independent investigators
to ensure reproducibility.116 The reanalyses validated the
quality of the data and replicated the original results without
any substantial alteration in findings. Although exposure to
ambient air pollution poses smaller relative risks for incident
cardiovascular disease than obesity or tobacco smoking,
because it is ubiquitous, the absolute number of people
affected is enormous, and exposure occurs over an entire
lifetime. The adverse effects on the public health are clearly
not limited to a harvesting effect as described earlier. Rather,
Pope78 has estimated an average loss of life expectancy
directly related to chronic air pollution exposure from be-
tween 1.8 and 3.1 years for those living in the most polluted
cities in the United States. Cardiovascular causes account for
the majority (69%) of the overall excess in morbidity and
mortality.78
Present Controversies
Given the continuous spatial and temporal variability of air
pollution, combined with individuals’ movements through
numerous microenvironments every day, it is not surprising
that exposure assessment in air pollution studies has always
been subject to varying degrees of measurement error. Gen-
erally, in the epidemiological studies, an individual subject’s
exposure level has been estimated from citywide pollution
measurement averages obtained from at most a few central
locations. Past studies have also been limited by the fact that the
numerous gaseous and particulate pollutants tend to covary in
time and space. This has limited the ability to confidently link
health outcomes with any given pollutant, although this may be
an unrealistic goal given the complexity of the ambient pollutant
mixture and the potential for combined toxic effects from many
different combinations of constituents. Use of new tools such as
geographic information systems and personal monitoring de-
vices and better measures of the full toxic air pollution mix (eg,
individual chemical and physical constituents or measurements
of total oxidant capacity) may provide more refined estimates of
the adverse health effects that can be related to specific (mixtures
of) components.
Despite many past limitations, there has been a strong
consistency in the findings among the array of assorted
studies. A reasonable argument can now be made that the
“real” effects are likely to be even stronger than previously
estimated. Indeed, a recent study suggests a more robust
linkage. In a recent “natural experiment,” Clancy et al117 were
able to demonstrate a decrease in health effects after the
intentional lowering of air pollutant levels. These investiga-
tors compared 72 months of mortality data before and after a
ban on burning coal within the city of Dublin, Ireland, went
into effect. Nontraumatic deaths decreased by 5.7% (95% CI
4.0% to 7.0%) and cardiovascular mortality by 10.3% (95%
CI 8.0% to 13.0%). The authors estimated that the ban
resulted in 243 fewer cardiovascular deaths per year. The
decrease in the mortality rate in this “natural experiment” is
more than twice what would be predicted by the short-term
time-series analyses.
Potential Biological Mechanisms
The putative biological mechanisms linking air pollution to
heart disease involve direct effects of pollutants on the
cardiovascular system, blood, and lung receptors, and/or
indirect effects mediated through pulmonary oxidative stress
and inflammatory responses. Direct effects may occur via
agents that readily cross the pulmonary epithelium into the
circulation, such as gases, and possibly UFPs28–30 along with
soluble constituents of PM2.5 (eg, transition metals). In addi-
tion, activation of pulmonary neural reflexes secondary to PM
interactions with lung receptors may play a role. Ensuing
alterations in autonomic tone, under appropriate circum-
stances, might contribute to the instability of a vascular
plaque or initiate cardiac arrhythmias. These direct effects of
air pollution represent a plausible explanation for the occur-
rence of rapid (within a few hours) cardiovascular responses,
such as increased myocardial infarctions.11 Less acute (sev-
eral hours to days) and chronic indirect effects may occur via
pulmonary oxidative stress/inflammation induced by inhaled
pollutants. This subsequently may contribute to a systemic
inflammatory state, which may in turn be capable of activat-
ing hemostatic pathways, impairing vascular function, and
accelerating atherosclerosis. A general scheme illustrating
potential mechanisms of the effects of PM on the cardiovas-
cular system is shown in Figure 2.
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Pulmonary and Systemic Oxidative Stress
and Inflammation
Inhalation of air pollutants induces pulmonary oxidative
stress and inflammation.118 Exposure of human lungs to
concentrated PM119 and O3120 produces an inflammatory
response consistent with in vivo animal models121 and in vitro
cellular models.122–125 The presence of soluble transition
metals in PM enhances the inflammatory responses126 via
increased oxidative stress.127,128 However, lung inflammation
may also occur via direct UFP effects independent of transi-
tion metals or soluble components.129 Similarly, O3 mediates
a pulmonary inflammatory response via oxidative stress118,130
and an impairment in lung function that can be attenuated by
antioxidants.131
Oxidative stress occurs after exposure to ultrafine carbon
black and diesel exhaust particles (DEPs),129,132 ambient
PM2.5,133 and cigarette smoke. A recent in vivo experiment
using in situ chemiluminescence demonstrated the rapid
occurrence of oxidative stress even in tissues beyond the
lung. After exposure to concentrated ambient PM2.5 for 2
hours, there was a doubling in reactive oxygen species
generation in the hearts and lungs of rats.134 This may occur
in response to a variety of transition metals134 or free radical
components known to exist within PM2.5 as a result of
atmospheric chemical reactions.135 Personal exposure to am-
bient concentrations of PM2.5 is also associated with increased
levels of markers of lipid and protein oxidation in human
blood.133 Pulmonary inflammation results at least in part
because of the increased production of free radicals.118
Oxidative stress activates specific transcription factors, in-
cluding nuclear factor-B and activator protein-1, which
upregulate the expression of genes for cytokines, chemo-
kines, and other proinflammatory mediators.132 DEPs or
organic extracts of DEPs can, through oxidant effects on
mitochondria, induce apoptosis or necrosis of macrophages
and respiratory epithelial cells, possibly decreasing the host
defenses to respiratory infection or increasing airway
reactivity.136
Endotoxin, usually associated with coarse particles, has
also been shown to induce proinflammatory cytokine produc-
tion137,138; increase lung inflammation, airway responsive-
ness, and systemic immune cell populations; and decrease
lung function.139,140 Endotoxin has been found to account for
in vitro cytotoxicity and cytokine production related to PM2.5
and coarse PM exposures141,142; however, its role in the
overall toxicity of ambient PM remains to be clarified.
The intrapulmonary responses elicited by PM may also be
due in part to neurogenic inflammation. Sensory neurons in
contact with irritant particles (eg, within the conducting
airways) can be stimulated to release neuropeptides (eg,
substance P, calcitonin gene related peptide, and neurokinin
A), which can initiate airway inflammatory events, including
release of cytokines, vasodilation, and mucus secretion.
Neuropeptides act on a variety of cell types within the lung,
including epithelial and smooth muscle cells (resulting in
modulation of inflammation and increased airway respon-
siveness), as well as immune cells (polymorphonuclear leu-
kocytes [PMNs], lymphocytes, eosinophils, and others), thus
amplifying the inflammatory response. Recent in vitro exper-
iments indicate that specific irritant (capsaicin or vanilloid)
Figure 2. Possible biological mecha-
nisms linking PM with cardiovascular
disease.
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receptors on neurons mediate PM-related neurogenic inflam-
mation, as evidenced by responses to particles originating
from diverse sources.143
Several controlled-exposure studies demonstrate that inha-
lation of particles119,144,145 and O3120 evokes both a pulmonary
and a systemic inflammatory response in humans. One hour
of exposure to very high concentrations of diesel exhaust has
been shown to induce an inflammatory reaction in the lungs
of healthy adults. This response included increased numbers
of PMNs, T- and B-lymphocytes, mast cells, and inflamma-
tory mediators.144 One of these studies showed an increase in
adhesion molecules that facilitate the passage of inflamma-
tory cells from the circulation into the airways. In the blood,
platelets and PMNs increased, which suggests that exposure
to DEPs stimulated the bone marrow to release these cells
into the circulation.
Exposure to DEP has been shown to increase intra-airway
transcription of mRNA for interleukin (IL)-8 (a protein that
attracts PMNs to sites of injury)146 and increased production
of IL-8 and growth-regulating oncogene- (GRO)-promoting
airway inflammation. Exposure of healthy adults to concen-
trated ambient particles (CAP) for 2 hours can increase
airway inflammation without concomitant lung injury.119
Nevertheless, plasma fibrinogen was elevated by the CAP
exposure relative to filtered air. This controlled exposure
study suggests that exposure to ambient particles in healthy
humans can result in a mild pulmonary inflammatory re-
sponse and increased blood factors that effect coagulation,
even without lung damage. A similar human study also
demonstrated an increase in blood fibrinogen after short-term
exposure to CAP.147 However, no other changes in inflam-
matory mediators or other coagulation factors were found.
Additional studies support the existence of a systemic
inflammatory response beyond the lungs after air pollution
exposure. In humans, exposure to forest fire smoke (mea-
sured as PM10 and SO2) at levels that did not result in changes
in lung function nevertheless resulted in stimulation of bone
marrow to release immature PMNs into the circulation.148
In an animal experiment, rabbits that received 5 mg of
PM10 intrapharyngeally twice per week for 3 weeks exhibited
increased production of PMNs in the bone marrow and
accelerated release into the circulation.149 The PM10 exposure
resulted in diffuse inflammation of the lungs, with particles
present in alveolar macrophages, lung epithelial cells, and
airway walls. The effects on PMN production in bone marrow
and release of immature cells into the blood were associated
with the numbers of particles ingested by alveolar
macrophages.
Effects of Inflammation, Oxidative Stress, and
Alterations in Blood-Borne Factors on the
Cardiovascular System
Changes in the composition of the blood may result from air
pollution exposure, with potentially serious effects on indi-
viduals with cardiovascular disease. Nearly a decade ago,
Seaton et al150 proposed a general hypothesis that exposure to
inhaled particles induces alveolar inflammation, leading to
exacerbation of preexisting lung disease, increased blood
coagulability, and an associated increased risk of cardiovas-
cular events. Subsequently, evidence supporting this hypoth-
esis has slowly been accumulating. As described above,
several studies of controlled exposures to particles demon-
strate increases in both cellular and biochemical markers of
pulmonary and systemic inflammation.
Exposure to PM increases fibrinogen,119,147 a key compo-
nent in blood coagulation and platelet thrombosis and a major
determinant of blood viscosity. Blood viscosity has been
associated with severity of cardiovascular disease151 and has
been found to increase in association with increased levels of
ambient total suspended particles and SO2.152 Fibrinogen is
also well established as an important independent risk factor
for myocardial infarction and stroke. Epidemiological data
suggest potential effects of particulate air pollution on blood
coagulation.152–154 Of note is that the strength of plasma level
of fibrinogen to predict cardiac events and death in middle-
aged men is modified by the presence of other inflammation-
sensitive proteins,155 which suggests that inflammation has a
significant role in the determination of cardiovascular risk. In
addition, enhanced platelet aggregation may further promote
acute thrombosis formation after exposure to diesel ex-
haust156 and UFPs.157 The mechanisms responsible for plate-
let activation and fibrinogen elevation remain to be fully
elucidated. Nevertheless, these findings support the notion
that air pollution can acutely increase the risk of thrombosis,
thus promoting ischemic events.
Increased concentrations of IL-6 are associated with an
increased risk of cardiovascular events158,159 and mortality.160
Serum Il-6, IL-1, and granulocyte macrophage colony-
stimulating factor are increased in healthy male subjects after
exposures to increased air pollution due to forest fires and are
increased in vitro with exposure of human lung macrophages
to urban PM10.161 Il-6 is directly involved in regulation of the
synthesis of C-reactive protein in the liver. CRP is a sensitive
indicator of infection, injury, and inflammation and is linked
to increased risk of cardiovascular disease.162,163 CRP con-
centration has been shown to be positively associated with
exposure to total suspended particles164 and PM10.153
The mechanisms by which CRP increases the risk of
cardiovascular events is the subject of intense research. One
possibility is that CRP impairs endothelial vasoreactivity in
individuals with preexisting coronary artery disease.165 In
addition, CRP may contribute directly to the development and
progression of atherosclerosis via a number of mechanisms
that involve enhanced formation of foam cells, recruitment of
monocytes into the arterial wall, stimulation of prothrombotic
tissue factors, decreased NO synthase activity, and expression
of adhesion molecules.166 Inflammation (proinflammatory
cytokines, CRP, and components of innate immunity) plays a
significant role in the genesis of atherosclerosis and in plaque
instability.167 It is possible, therefore, that air pollution–
mediated systemic inflammation both promotes atherosclero-
sis formation over the long term14 and instigates acute plaque
instability and sudden cardiovascular events in the short term.
Indeed, in hyperlipidemic rabbits exposed to PM, the pro-
gression of coronary atherosclerosis and extracellular lipid
pools increased after 4 weeks.14 The degree of plaque
formation correlated with the number of alveolar macro-
phages that phagocytosed PM. These effects are likely to be
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superimposed on the effects of age, hypertension, hyperlip-
idemia, diabetes, and other conditions associated with under-
lying inflammation.
Alterations in vascular tone due to air pollution exposure
have also been demonstrated. The inhalation of high urban
levels of CAP and ozone for 2 hours caused conduit arterial
vasoconstriction in healthy adults.168 Similarly, small pulmo-
nary arteries were shown to constrict after short-term expo-
sure to CAP in rats.169 It is possible that the acute systemic
inflammation and oxidative stress133,134 are responsible for
triggering endothelial dysfunction leading to vasoconstric-
tion.170 In support of this hypothesis, impaired arterial endo-
thelial relaxation and decreased NO formation have been
shown to occur in vessels exposed to DEPs owing to excess
reactive oxygen species generation.171 Alternatively, in-
creased production of endothelins may play a role in the acute
vasoconstriction.172
At present, the precise mechanisms underlying the rapid
alterations in vascular tone remain to be resolved. However, a
few published reports support the relevance of these findings by
demonstrating an effect of air pollution on cardiovascular he-
modynamics.100,172 Ambient air pollution increases blood pres-
sure in cardiac rehabilitation patients173 and in adults with lung
disease.174 Indeed, arterial vasoconstriction is a likely explana-
tion for the findings of the ULTRA study (The Exposure and
Risk Assessment for Fine and Ultrafine Particles in Ambient
Air). Ambient levels of PM 2 days before submaximal exercise
testing were significantly associated with increased ST-segment
depression during the test.17 This finding suggests that air
pollution exposure conveys a greater susceptibility to myocar-
dial ischemia, as demonstrated in an experimental study of dogs
exposed to CAP.175 These results also offer insight regarding the
relationship between exposure to PM and the timing of AMI.11
Significant associations were identified between symptom onset
and both acute (levels within 2 hours before symptoms) and
subacute (previous-day average concentration) exposures to
PM2.5. Sudden arterial vasoconstriction (and/or possibly en-
dothelial dysfunction) could conceivably instigate acute cor-
onary syndromes by triggering plaque instability or by
decreasing myocardial perfusion in patients with existing
atherosclerosis.
Disturbances of the Cardiac Autonomic
Nervous System
Mortality associated with air pollution might be further
explained, at least in part, by alterations in the autonomic
input to the heart. HRV, resting heart rate, and blood pressure
are modulated by a balance between the 2 determinants of
autonomic tone (the sympathetic and parasympathetic ner-
vous systems). Decreased HRV predicts an increased risk of
cardiovascular morbidity and mortality in the elderly and
those with significant heart disease.176 This is generally
determined by analyses of time (eg, standard deviation of
normal RR intervals [SDNN]) and frequency domains (eg,
low frequency/high frequency ratio by power spectral analy-
sis, reflecting autonomic balance) measured during 24 hours
of electrocardiography. Because overall HRV (SDNN) de-
creases in response to ambient PM exposure,177–181 decreased
parasympathetic input to the heart may provide an important
mechanistic link between air pollution and cardiovascular
mortality by promoting fatal tachyarrhythmias. A recent
study of controlled exposure to CAP provides further support
to the notion that PM is capable of reducing HRV.182 In
general, the decrease of HRV occurs rapidly and is inversely
proportional to the increase in the concentration of PM.
However, in one study,177 short-term measures of parasym-
pathetic tone (r-MSSD) were increased in a group of individ-
uals with preexisting heart disease. It is conceivable that in
certain populations, air pollution–mediated bradyarrhythmias
may also contribute to sudden death.
The relevance that these observed short-term changes in
HRV have in relation to the worsening of cardiovascular
outcomes and the triggering of significant arrhythmias over
the long term remains unclear. However, some evidence
suggests that PM exposure does promote clinically meaning-
ful changes in cardiac electrophysiology. The incidence of
cardiac arrhythmias has been associated with exposure to
PM2.5 in high-risk individuals (eg, individuals having an
implanted cardioverter defibrillator). In 100 patients moni-
tored for 3 years, NO2 and CO concentrations were most
strongly related to implanted cardioverter defibrillator dis-
charges, whereas particulate black carbon showed a slightly
lesser degree of association with such events.18 Although this
study is limited by the small number of high-risk patients and
by the lack of individual clinical data beyond implanted
cardioverter defibrillator discharges, it does suggest a poten-
tial for adverse effects of PM and gaseous pollutants on
cardiac autonomic balance. A recent mortality time-series
study98 further supports this observation. The risks of mor-
tality from threatening arrhythmias were shown to increase in
relation to 7-day mean levels of black smoke and PM10.
These clinical observations are consistent with several
studies reporting the induction of cardiac arrhythmias in
compromised animals (ie, with pulmonary and systemic
hypertension) exposed to PM.183 Dogs exposed to CAP for 6
hours on 3 consecutive days showed increases in low- and
high-frequency HRV, as well as an elevated low frequency/
high frequency ratio.184 In addition, exposure to residual oil
fly ash, a component of PM, decreased HRV and increased
arrhythmia frequency in a myocardial infarction model of
rats.185 These animal exposure findings support the notion
that air pollution is capable of altering autonomic balance in
a manner that favors significant tachyarrhythmias. The un-
derlying mechanisms responsible remain unclear but may
involve activation of pulmonary neural reflex arcs, direct
effects of pollutants on cardiac ion channels, or consequences
of the heightened systemic inflammatory state.
Summary
Air pollution consists of a complex mixture of compounds in
gaseous (eg, NO2, SO2, CO, O3), liquid, and solid phases. PM
itself is a heterogeneous mixture of suspended particles that
vary in chemical composition and size, ranging from clusters
of molecules (with diameters of several nanometers) to coarse
PM (up to 10 m and beyond). Among the many natural and
anthropogenic sources of air pollution, the combustion of
fossil fuels is a major contributor in urban and industrialized
societies.
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Numerous epidemiological studies conducted worldwide
have demonstrated consistent associations between short-
term elevations in PM and increases in daily cardiovascular
morbidity and mortality. Several studies have also reported
adverse cardiovascular outcomes in relation to long-term PM
exposure. Elderly patients, those with underlying coronary or
pulmonary disease, lower socioeconomic populations, and
diabetics may be at particularly increased risk. At present, the
constituent PM responsible for mediating these effects, along
with the roles of the various gaseous copollutants, remain to
be clarified.
Experimental evidence has revealed plausible biological
mechanisms whereby PM has the potential to cause and
exacerbate cardiovascular disease. One pathway involves the
initiation of pulmonary and systemic oxidative stress and
inflammation by components within PM. Subsequently, a
cascade of physiological responses may follow that are
capable of instigating cardiovascular events. These include
alterations in blood rheology that favor thrombosis, cardiac
dysrhythmias, acute vascular dysfunction, plaque instability,
and the long-term development of atherosclerosis. Additional
pathways may also be involved, such as changes in auto-
nomic balance via lung neural reflex arcs and/or by PM (or
certain components) reaching the circulation and beyond.
Potential for Prevention/Public Policy
The increase in relative risk for cardiovascular disease due to
air pollution for an individual is small compared with the
impact of the established cardiovascular risk factors. How-
ever, because of the enormous number of people affected,
even conservative risk estimates translate into a substantial
increase in total mortality within the population. The impact
on cardiovascular disease therefore represents a serious pub-
lic health problem. The latest draft of the US EPA Air Quality
Criteria for Particulate Matter has confirmed the presence of
an apparent linear dose-response relationship between PM
and adverse events.186 Data from all North American studies
demonstrate that this curve is without a discernible threshold
below which PM concentrations pose no health risk to the
general population.186 At present-day levels, 40 000 deaths
per year in Austria, France, and Switzerland combined have
been attributed to PM.187 Estimates based on time-series
studies suggest that 5000 excess deaths per year in Cana-
da188 and 6000 cardiovascular events in the United King-
dom189 can be attributed to poor air quality. Approximately 1
in 50 myocardial infarctions were thought to be triggered by
outdoor air pollution in a London, England, study.3 On a
global scale, the World Health Organization has estimated
that 800 000 deaths occur per year and 7.9 million disability-
adjusted life-years are lost annually due to PM exposure.189a
Given the burden of epidemiological evidence, the US
EPA updated the National Ambient Air Quality Standards in
1997 to specifically include PM2.5 (Table).190 The most
current estimates by the EPA suggest that attainment of these
standards would reduce total mortality by 23 000 deaths
annually and cardiovascular hospital admissions by 42 000
per year in the United States.191 Nevertheless, 19% of all US
counties with air-quality monitoring systems are presently not
meeting these standards.192 This percentage is substantially
greater in regions such as the industrial Midwest (41%) and
southern California (60%). In light of these data, there is a
clear potential to improve the national public health and to
substantially reduce cardiovascular morbidity and mortality
by reducing PM levels to current EPA standards. The poten-
tial cardiovascular health effect of reducing the gaseous
copollutants remains less certain.
Conclusions and Recommendations
Most3–8,81 but not all12,13 studies have found positive associ-
ations between several different air pollutants and adverse
health outcomes. The results of observational studies are
influenced by numerous factors, including characteristics of
the air pollution, the population studied, and methodological
issues, such as control of relevant confounders. The lack of
complete uniformity is not surprising given that numerous
variables (atmospheric conditions, geographic locations, co-
hort characteristics, sample sizes, exposure estimates, and
statistical modeling) can affect the results. Our understanding
of the relevant biological mechanisms involved also remains
incomplete. Nevertheless, the existing body of evidence is
adequately consistent, coherent, and plausible enough to draw
several conclusions.193 At the very least, short-term exposure
to elevated PM significantly contributes to increased acute
cardiovascular mortality, particularly in certain at-risk subsets
of the population. Hospital admissions for several cardiovas-
cular and pulmonary diseases acutely increase in response to
higher ambient PM concentrations. The evidence further
implicates prolonged exposure to elevated levels of PM in
reducing overall life expectancy on the order of a few years.
On the basis of these conclusions and the potential to
improve the public health, the AHA writing group supports
the promulgation and implementation of regulations to expe-
dite the attainment of the existing National Ambient Air
Quality Standards. Moreover, because a number of studies
have demonstrated associations between particulate air pol-
lution and adverse cardiovascular effects even when levels of
ambient PM2.5 were within current standards,5,11 even more
stringent standards for PM2.5 should be strongly considered by
the EPA. Additional approaches to reduce the burden of
disease related to air pollution should be highlighted. The
levels of O3 and PM in many US cities are published daily by
the EPA, along with a health alert system that reflects
recommended changes in activity. This information is also
available and updated daily on the EPA AIRNow web site
(http://www.epa.gov/airnow). The AHA supports these rec-
ommendations as guidelines for activity restriction for per-
Current US EPA National Ambient Air Quality Standards for PM
(1997 NAAQS)
Time Period PM10, g/m3 PM2.5, g/m3
Annual 50 15
Daily 150 65
The annual standard is satisfied when the 3-year average of the mean PM
levels measured in a community is less than or equal to the indicated number.
The daily standard is met when the 3-year average of the 98th or 99th
percentile of 24-hour PM levels in each community is less than or equal to the
indicated number.
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sons with known heart disease (or with an “at-risk” profile by
Framingham or another scoring system), and pulmonary
disease, the elderly, and those with diabetes mellitus. A
concerted effort should be made to educate healthcare pro-
viders and at-risk patients alike about this source of informa-
tion and about the potential health hazards of elevated air
pollution levels. The AHA should also actively work to
educate the public and public policy makers about the effects
of air pollution on cardiovascular disease by featured presen-
tations at the annual Scientific Sessions, AHA-sponsored
public education activities, and advocacy.
In October 2003, the EPA expanded its Air Quality Index
program to include information on particle pollution, or fine
particles. Next-day forecasts and real-time air quality informa-
tion about particle pollution are available on the AIRNow Web
site for more than 150 cities across the country. Air quality
forecasts and reports for particle pollution are available in the
local media (newspapers, television, and radio) in these cities
and in the national media. The EPA is working to increase the
number of state and local air quality agencies that forecast and
report real-time particle pollution levels. It is expected that
within a few years, this program will mirror the O3 program in
terms of geographic coverage and availability to the public. The
AIRNow Web site also contains information about the health
effects of particle pollution, and the EPA is developing a section
with information and tools for healthcare professionals.
Although there is a strong case that air pollution increases
the risk of cardiovascular disease, we recognize the need to
address a number of remaining scientific questions. Both the
US EPA and the National Institutes of Health have increased
the priority of research funding in an effort to overcome these
shortcomings, and a committee of the National Research
Council set out a long-range research agenda in 1998.194 A
workshop sponsored by these and other agencies was con-
vened in August 2002 to foster multidisciplinary research on
the cardiovascular effects of PM. The AHA writing group
supports these measures and recognizes several important
areas for future research80,192:
1. Improve our understanding of the underlying biological
mechanisms.
• Better describe the basic mechanisms (mediators, cell
signaling, pathways) involved in altering HRV (auto-
nomic tone), vascular function, and atherogenesis.
• Increased use of relevant animal models of exposure
when investigating cardiovascular outcomes (eg, in-
halation chambers at meaningful CAP concentra-
tions). Experiments using intrapulmonary installation
provide insight into basic mechanisms; however, the
ability to extrapolate findings to humans is limited
owing to the route of administration of extraordinarily
high quantities of PM.
• Determine the pathophysiological relevance of the
many pathways that may contribute to the develop-
ment of both acute and chronic disease.
• Demonstrate reproducibility of the relevant potential
mechanisms under a variety of pollutant regimens and
subject risk profiles.
• Demonstrate the occurrence of such cardiovascular
end points at environmentally relevant concentrations
of ambient pollutants.
• Determine causal pathways, which may become tar-
gets for future means of preventive strategies
• Determine whether long-term exposure to PM at
environmentally relevant concentrations promotes the
genesis/progression of atherosclerosis in humans.
2. Identification of the differential toxicity of various
constituents and sources of air pollution, including:
• Specific chemical and biological constituents of PM
(eg, metals, carbon, polycyclic aromatic hydrocar-
bons, endotoxin).
• The role of different PM size fractions, including
UFPs (0.1 m) and the coarse fraction (PM10 to 2.5).
• The effects of gaseous copollutants alone or in com-
bination with PM.
3. Epidemiological investigations designed to address
some of the limitations of prior reports, including
studies that involve the following:
• Better characterization of the populations of individ-
uals at high risk related to short-term elevations in
PM (eg, comorbidities).
• Improvement of exposure estimates and metrics (eg,
use of personal monitoring systems).
• Examination of the relationships between traffic
emissions and adverse cardiac effects.
• Investigation of the roles of copollutants and
confounders.
• Assessment of the effect of medications on the acute
cardiovascular effect of air pollution (eg, HMG-CoA
reductase inhibitors).
• Evaluation of the shape of the dose-response curve
(identification of any threshold concentrations of
various pollutants).
• Improved estimations of the population-wide health
benefits of reducing PM and other pollutants.
• More thorough examination of the relationships be-
tween ambient air pollution concentrations and ad-
verse reproductive outcomes, including those involv-
ing congenital cardiac anomalies
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